HIV infection
Conditions
Interventions
Comparison between conventional method and new test
Sponsors
Keio University School of Medicine Center for Infectious Disease and Infection Control
Kanagawa Prefectural Institute of Public Health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Disease group 1) Patient with HIV infection. 2) Enable to obtain the written informed consent. Healthy group 1) HIV-non infected.
Exclusion criteria
Exclusion criteria: Disease group 1) Patient who have been infected for HIV within one month. 2) Unable to have sighed informed consent. 3) Patients whose phycian consider the study enrollment inappropreate. Healthy group 1) HIV infected 2) Uncontrolled diabetes 3) Tumor-bearing 4) Taking immunosuppressive drug 5) Patients whose physician consider the study enrollment inappropreate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance between new test and western-blot analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Concordance between new test and HIV-antibody test which is used for HIV infection screening | — |
Countries
Japan
Contacts
Public ContactShingo Kato
Keio University School of Medicine Department of Microbiology and Immunology
Outcome results
None listed